3-(Indol-2-yl)quinoxalin-2-ones has already been reported as an anti-angiogenesis agent by Ladouceur et al.
3-(Indol-2-yl)quinoxalin-2-ones has already been reported as an anti-angiogenesis agent by Ladouceur et al. 1) These compounds have a potent inhibitory effect on the growth of tumor cells with angiogenesis activity. We have also carried out a structure-activity relationship (SAR) study of 3-(indol-2-yl)quinoxalin-2-ones, which showed a potent inhibitory activity toward the VEGF-induced proliferation of human mesangial cells and the VEGF-induced auto-phosphorylation of human umbilical vein endothelial cells.
2) Moreover, these compounds have a potent medicinal effect based on anti-angiogenic action, by oral administration 2) (Chart 1, 9). On the other hand, as shown in Chart 2, the two conventional synthetic method 1) of 3-(indol-2-yl)quinoxalin-2-ones VI had been also reported. One of them is the A-route consisting of the crossing coupling of (indol-2-yl)boric acids with 2,3-dichloroquinoxalines. Another is the B-route in which (indol-2-yl)oxoacetate is condensed with phenylenediamine. In the case of the former, II was prepared by the reaction of I, which was protected at the 1-position of indole with a suitable protecting group, with a boric acid ester using an alkyl lithium reagent. Then III was prepared by the crossing coupling of II with 2,3-dichloroquinoxalines, which had previously been prepared separately. This route requires strict anhydrous conditions and low temperature. Moreover, two kinds of regioisomers of III might be generated by the coupling reaction of II with the substituted 2,3-dichloroquinoxalines. On the other hand, in the case of the latter route, the preparation of IV also needs strict anhydrous conditions and low temperature like A-route. In addition, V may be obtained as two different regioisomers by the reaction of IV with the substituted phenylenediamines. When more complicated derivatives are prepared for more extensive SAR studies, it could be expected that the number of steps would increase because the protection and/or de-protection of intermediates are necessary in both routes. Therefore, a new and simple synthetic method, using highly regiospecific reactions and minimizing protection/de-protection steps as much as possible, was desired for the SAR study of these derivatives. We have already reported the direct condensation 3) of indole or 7-azaindole with various substituted quinoxalin-2-ones in the presence of TFA, which proceeds under mild conditions (Chart 3, C). In this reaction, the desired products are obtained by heating a mixture of indoles and quinoxalin-2-ones in DMF in the presence of 10% (v/v) TFA, followed by treating with suitable oxidizers such as MnO 2 . Therefore, it was thought that the similar reaction 4) via the indolenine and/or direct pathway 5) of 3-substituted indoles with quinoxalin-2-ones might proceed and, as expected, the desired 3-(indolyl-2-yl)quinoxalin-2-ones can be prepared under these mild conditions (Chart 3, D) .
Chemistry
Thus, the TFA-catalyzed condensation of 1a with quinoxalin-2-ones in dichloromethane (DCM) was actually carried out. As Table 1 shows, the reaction proceeded quite fast even at room temperature and afforded the desired product 2a in 60% of yield (Entry 1). In this TFA-catalyzed condensation, only the desired product was obtained by stirring a mixture of 3-methylindole and quinoxalin-2-one in DCM in the presence of 10% (v/v) TFA, followed by a certain oxidation 6) in situ, without generating any saturated side products, 3) unlike that observed in C (Chart 3). The structure of 2a has been determined by alternative synthesis employing the similar process, 1) as depicted in Chart 4. The various 3-substituted indoles react with quinoxalin-2-ones in DCM or 1,2-dichloroethane (DCE), and the reaction is compatible with functional groups which are sensitive to strong base (see Table 1 , Entry 3-6). Generally, the coupling reaction of in- doles bearing a substituent which raises the electron density on the ring tends to proceed promptly. However, in the case of 1f, in which the electron density on the ring is lowered, an unexpected reaction accompanying decarobxylation proceeded to give 2h 3, 7) in about 20% yield (Entry 7). The reaction of derivatives of 1a, in which the indole was protected at 1-position with an electron withdrawing substituents such as a benzenesulfonyl group, 8) also failed. The TFA-catalyzed condensation of (3-indoxyl)acetate 1g with quinoxalin-2-ones lead to decomposition of 1g (Entry 8). The reaction using the indole 1h, which does not have a substituent at the 3-position, afforded only 2h, 3, 7) in which substitution had taken place at the 3-position on the indole, in about 40% yield (Entry 9).
We then applied the new synthetic method to the preparation of a series of our VEGF inhibitors and give an example of their preparation here (Chart 5). The formylation of 5 using the method of Bergman 9) afforded 6 in 91% yield. Then, the reduction 10) of 6 with 10% Pd-C and sodium tetrahydroborate in 2-propanol gave 7 in 84% yield. The protection of the 1-position on the indole ring of 7 by tertBoc 2 O, followed by de-benzylation with 10% Pd-C in AcOEt under hydrogen atmosphere, provided 8 in 95% yield after 2 steps. The coupling reaction of 8 with 1-(2-chloroethyl)piperidine in the presence of cesium carbonate (Cs 2 CO 3 ) in DMF, followed by the TFA-catalyzed condensation with 6-fluoroquinoxalin-2-ones, 4) easily provided 9 in reasonable yield without further purification. In this method, 9 could be prepared easily owing to the facile de-protection of tert-Boc under the TFA-catalyzed reaction condition.
In summary, we investigated a convenient and simple synthetic method for 3-(3-substituted indol-2-yl)quinoxalin-2-ones and demonstrated a concise synthesis of 9, which may be a promising VEGF inhibitor. Moreover, since it is not necessary for our synthetic method to be carried out under strict anhydrous conditions and does not require special purification in the work-up process, it is likely that this reaction will be a very useful method in order to synthesize the concerned basic framework.
Experimental
The General Procedure for the Synthesis of 2a, 2b, 2c, 2d, 2e and 2h. 3-(3-Methylindol-2-yl)quinoxalin-2-ones, 2a To a mixture of 3-methylindole (65.5 mg, 0.5 mmol) and quinoxalin-2-ones (73.1 mg, 0.5 mmol) in DCM (2.5 ml) was added TFA (0.2 ml) at room temperature, and then the reaction mixture was allowed to stir for 2 h at room temperature. The resulting reaction mixture was diluted with AcOEt, washed with saturated Na 2 CO 3 aq., and the organic phase then dried over Na 2 SO 4 . After removing the organic solvent in vacuo, the residue was triturated in a small amount of MeOH. Alternative synthesis of 2a. Methyl 1-(tert-Butoxycarbonyl)-3-methyl-1H-indole-2-glyoxylate, 4 To a solution of 3 (3.00 g, 12.9 mmol) in DCM (50 ml) was added dropwise tert-butyl lithium (1.57 mol/l in pentane, 9.0 ml, 14.2 mmol) during 20 min period at Ϫ78°C, and then the reaction mixture was allowed to stir for 1 h at Ϫ78°C. A solution of dimethyl oxalate (3.92 g, 33.2 mmol) in DCM (25 ml) was added to the stirring reaction mixture at Ϫ78°C, and then the reaction mixture was stirred at Ϫ78°C for 1 h. The resulting reaction mixture was quenched with saturated NH 4 Cl aq., and the
